Stay updated with breaking news from Synlogic Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A four-day week shortened by Labor Day still brought substantial news in the cannabis sector. “Even though this week was a shortened trading week, there were still lots of financial deals happening. Cronos Group agreed to a partnership with Gingko Bioworks that could be worth $122... Read More... Don't Miss Any Updates! News Directly in Your Inbox Subscribe to:
Synlogic Announces Proposed Public Offering of Common Stock News provided by Share this article Share this article CAMBRIDGE, Mass., April 15, 2021 /PRNewswire/ -- Synlogic (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced that it has commenced an underwritten public offering of its common stock. All shares of common stock to be sold in the offering will be offered by Synlogic. Synlogic intends to grant the underwriter a 30-day option to purchase up to an aggregate of an additional 15% of the shares of its common...
Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research (AACR) Annual Meeting - Data demonstrates activation of STING pathway in patients - - Combination arm of Phase 1 study of SYNB1891 ongoing - News provided by Share this article Share this article CAMBRIDGE, Mass., April 10, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today presented data on SYNB1891 for the treatment of solid tumors and lymphoma during the American Association for Cancer Researc...
Synlogic to Present at Upcoming Virtual Banking and Industry Conferences News provided by Share this article Share this article CAMBRIDGE, Mass., April 1, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced that Aoife Brennan, M.B. Ch.B., Synlogic's President and Chief Executive Officer, and other members of the executive team will present at the following virtual banking and industry conferences: 20 th Annual Needham Virtual Healthcare Conference: Dr. Brennan and Daniel Rosan, SV...
/PRNewswire/ -- Synlogic, Inc. (NASDAQ: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced...